Viewing Study NCT02048020


Ignite Creation Date: 2025-12-25 @ 4:18 AM
Ignite Modification Date: 2026-03-02 @ 6:43 PM
Study NCT ID: NCT02048020
Status: COMPLETED
Last Update Posted: 2018-08-14
First Post: 2014-01-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer
Sponsor: Jonsson Comprehensive Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Human Papilloma Virus Infection View
None Stage III Squamous Cell Carcinoma of the Hypopharynx View
None Stage III Squamous Cell Carcinoma of the Larynx View
None Stage III Squamous Cell Carcinoma of the Oropharynx View
None Stage III Verrucous Carcinoma of the Larynx View
None Stage IV Squamous Cell Carcinoma of the Hypopharynx View
None Stage IV Verrucous Carcinoma of the Larynx View
None Stage IVA Squamous Cell Carcinoma of the Larynx View
None Stage IVA Squamous Cell Carcinoma of the Oropharynx View
None Stage IVA Verrucous Carcinoma of the Larynx View
None Stage IVB Squamous Cell Carcinoma of the Larynx View
None Stage IVB Squamous Cell Carcinoma of the Oropharynx View
None Stage IVB Verrucous Carcinoma of the Larynx View
None Stage IVC Squamous Cell Carcinoma of the Larynx View
None Stage IVC Squamous Cell Carcinoma of the Oropharynx View
None Stage IVC Verrucous Carcinoma of the Larynx View
Keywords: